Daniel Abdun-Nabi - 03 Aug 2016 Form 4/A - Amendment Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: Director
Signature: /s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol: APVO
Transactions as of: 03 Aug 2016
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 07 Mar 2023, 15:38:35 UTC
Date Of Original Report: 05 Aug 2016
Next filing: 02 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	APVO	Common Stock						41,762	03 Aug 2016	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares has been adjusted to reflect the correct number of shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016. On March 26, 2020, the Issuer effected a reverse stock split at a ratio of 1-for-14, resulting in every 14 shares owned by the reporting person to be combined into one share of common stock, thus reducing the number of shares owned by the reporting person to 4,173 as of March 26, 2020.

Content

The number of shares has been adjusted to reflect the correct number of shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016. On March 26, 2020, the Issuer effected a reverse stock split at a ratio of 1-for-14, resulting in every 14 shares owned by the reporting person to be combined into one share of common stock, thus reducing the number of shares owned by the reporting person to 4,173 as of March 26, 2020.